Nalaganje...
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Trabectedin (ET743, Yondelis(®), manufactured by Baxter Oncology GmbH, Halle/Westfalen, Germany, for Janssen Products, LP, Horsham, PA), derived from the marine ascidian, Ecteinascidia turbinata, is a natural alkaloid with multiple complex mechanisms of action. On 23 October 2015, 15 years after the...
Shranjeno v:
| izdano v: | Adv Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939148/ https://ncbi.nlm.nih.gov/pubmed/27234989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0344-3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|